BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Lima L, Friedman L, Wang L, Xu P, Anderson M, Debabov D. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli. Antimicrob Agents Chemother 2012;56:2753-5. [PMID: 22354299 DOI: 10.1128/AAC.05985-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Rosenblatt J, Vargas-Cruz N, Reitzel RA, Raad II. Assessment of the Potential for Inducing Resistance in Multidrug-Resistant Organisms from Exposure to Minocycline, Rifampin, and Chlorhexidine Used To Treat Intravascular Devices. Antimicrob Agents Chemother 2019;63:e00040-19. [PMID: 30833430 DOI: 10.1128/AAC.00040-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Arnitz R, Stein M, Bauer P, Lanthaler B, Jamnig H, Scholl-Bürgi S, Stempfl-Al-Jazrawi K, Ulmer H, Baumgartner B, Embacher S, Geisler S, Gostner JM, Müllinger B, Kälz B, Nagl M. Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study. Ther Adv Respir Dis 2018;12:1753466618778955. [PMID: 29857780 DOI: 10.1177/1753466618778955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Joshi S, Mumtaz S, Singh J, Pasha S, Mukhopadhyay K. Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant Staphylococcus aureus. Sci Rep 2018;8:1021. [PMID: 29348589 DOI: 10.1038/s41598-017-17234-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
4 Mohammad H, Younis W, Ezzat HG, Peters CE, AbdelKhalek A, Cooper B, Pogliano K, Pogliano J, Mayhoub AS, Seleem MN. Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus. PLoS One 2017;12:e0182821. [PMID: 28797064 DOI: 10.1371/journal.pone.0182821] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
5 Turecka K, Chylewska A, Rychłowski M, Zakrzewska J, Waleron K. Antibacterial Activity of Co(III) Complexes with Diamine Chelate Ligands against a Broad Spectrum of Bacteria with a DNA Interaction Mechanism. Pharmaceutics 2021;13:946. [PMID: 34202624 DOI: 10.3390/pharmaceutics13070946] [Reference Citation Analysis]
6 Jekle A, Yoon J, Zuck M, Najafi R, Wang L, Shiau T, Francavilla C, Rani SA, Eitzinger C, Nagl M, Anderson M, Debabov D. NVC-422 inactivates Staphylococcus aureus toxins. Antimicrob Agents Chemother 2013;57:924-9. [PMID: 23208720 DOI: 10.1128/AAC.01945-12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
7 Mumtaz S, Behera S, Mukhopadhyay K. Lipidated Short Analogue of α-Melanocyte Stimulating Hormone Exerts Bactericidal Activity against the Stationary Phase of Methicillin-Resistant Staphylococcus aureus and Inhibits Biofilm Formation. ACS Omega 2020;5:28425-40. [PMID: 33195893 DOI: 10.1021/acsomega.0c01462] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gruber M, Moser I, Nagl M, Lackner M. Bactericidal and Fungicidal Activity of N-Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium. Antimicrob Agents Chemother 2017;61:e02527-16. [PMID: 28223376 DOI: 10.1128/AAC.02527-16] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 4.2] [Reference Citation Analysis]
9 Gottardi W, Debabov D, Nagl M. N-chloramines, a promising class of well-tolerated topical anti-infectives. Antimicrob Agents Chemother 2013;57:1107-14. [PMID: 23295936 DOI: 10.1128/AAC.02132-12] [Cited by in Crossref: 63] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
10 Grimus V, Coraça-Huber DC, Steixner SJM, Nagl M. Activity of N-Chlorotaurine against Long-Term Biofilms of Bacteria and Yeasts. Antibiotics (Basel) 2021;10:891. [PMID: 34438941 DOI: 10.3390/antibiotics10080891] [Reference Citation Analysis]
11 Romanowski EG. Is there an anti-adenoviral drug on the horizon? Expert Review of Ophthalmology 2014;8:427-35. [DOI: 10.1586/17469899.2013.831325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Naclerio GA, Onyedibe KI, Karanja CW, Aryal UK, Sintim HO. Comparative Studies to Uncover Mechanisms of Action of N-(1,3,4-Oxadiazol-2-yl)benzamide Containing Antibacterial Agents. ACS Infect Dis 2022. [PMID: 35297603 DOI: 10.1021/acsinfecdis.1c00613] [Reference Citation Analysis]
13 Tonoyan L, Fleming GTA, Mc Cay PH, Friel R, O'Flaherty V. Antibacterial Potential of an Antimicrobial Agent Inspired by Peroxidase-Catalyzed Systems. Front Microbiol 2017;8:680. [PMID: 28512449 DOI: 10.3389/fmicb.2017.00680] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tonoyan L, Fleming GTA, Friel R, O'Flaherty V. Continuous culture of Escherichia coli, under selective pressure by a novel antimicrobial complex, does not result in development of resistance. Sci Rep 2019;9:2401. [PMID: 30787338 DOI: 10.1038/s41598-019-38925-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]